Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis Intervention: Drug: thalidomide combined with dexamethasone and cyclophosphamide Sponsor: Peking Union Medical College Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dexamethasone | Histiocytosis | Hospitals | Langerhans Cell Histiocytosis (LCH) | Research